Profile
Trends
Explore the Research Trends
Research Network
Explore the Expert Network
Publications
-
1.
2013Feng Liu; Fengling Li; Anqi Ma; Elena Dobrovetsky; Aiping Dong; Cen Gao; Ilia Korboukh; Jing Liu; David Smil; Peter J. Brown; et al.
Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors
Journal of Medicinal Chemistry. 2013;56(5):2110-2124. -
2.
2013Lindsey I. James; Dalia Barsyte-Lovejoy; Nan Zhong; Liubov Krichevsky; Victoria K. Korboukh; J Martin Herold; Christopher J. MacNevin; Jacqueline L. Norris; Cari A. Sagum; Wolfram Tempel; et al.
Discovery of a chemical probe for the L3MBTL3 methyllysine reader domain
Nature Chemical Biology. 2013;9(3):184-191. -
3.
2012Qi Jin; Roderick S. Davis; Ann M. Bullion; Jian Jin; Yonghui Wang; Katherine L. Widdowson; Michael R. Palovich; James J. Foley; Dulcie B. Schmidt; Peter T. Buckley; et al.
Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups
Bioorganic and Medicinal Chemistry Letters. 2012;22(23):7087-7091.
Similar Experts
- Publications
- 624
- 358
- 55
- 54
- 137
Journals
-
Publications
-
20
-
10
-
4
-
3
-
2
Grants
-
1.
Gary Johnson; Shelton Earp; Shawn Gomez; Lee Graves; Jian Jin; Pei-Fen Kuan
Kinome Reprogramming in Response to Targeted Kinase Inhibitors
4/15/2012 - 1/31/2016
Sponsor: NIH National Institute of General Medical Sciences (NIGMS)
Funding: $ 278,929.00
-
2.
Gary Johnson; Shawn Gomez; Lee Graves; Jian Jin; Pei-Fen Kuan
Kinome Reprogramming in Response to Targeted Kinase Inhibitors
4/15/2012 - 1/31/2016
Sponsor: NIH National Institute of General Medical Sciences (NIGMS)
Funding: $ 249,720.00
-
3.
Jian Jin
c-Rel, a Novel Drug Target for Treating Multiple Sclerosis
6/1/2011 - 5/31/2013
Sponsor: University of Pennsylvania
Funding: $ 74,000.00
Institutional Network
-
Internal OrganizationsShared Pub.
-
8
-
3
-
3
-
3
-
3
-
2
-
External OrganizationsShared Pub.
-
31
-
10
-
7
-
4
-
2
-
2

